Issue 11, 2017

Dark chemical matter in public screening assays and derivation of target hypotheses

Abstract

Compounds that are consistently inactive in many screening assays, so-called dark chemical matter (DCM), have recently experienced increasing attention. One of the reasons is that many DCM compounds may not be fully inert biologically, but may provide interesting leads for obtaining compounds that are highly selective or active against unusual targets. In this study, we have systematically identified DCM among extensively assayed screening compounds and searched for analogs of these compounds that have known bioactivities. Analog series containing DCM and known bioactive compounds were generated on a large scale, making it possible to derive target hypotheses for more than 8000 extensively assayed DCM molecules.

Graphical abstract: Dark chemical matter in public screening assays and derivation of target hypotheses

Article information

Article type
Research Article
Submitted
18 Aug 2017
Accepted
20 Oct 2017
First published
26 Oct 2017

Med. Chem. Commun., 2017,8, 2100-2104

Dark chemical matter in public screening assays and derivation of target hypotheses

S. Jasial and J. Bajorath, Med. Chem. Commun., 2017, 8, 2100 DOI: 10.1039/C7MD00426E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements